Evaluation of Efficacy and Safety of Ashwadaat-TM Botanical Extract in Patients with Stress and Insomnia – An Open Label, Multi Center, Non-Comparative, Interventional, Prospective Clinical Study

Efficacy and Safety of Ashwadaat-TM in Patients with Stress and Insomnia

Authors

  • Dr. Sanjay Tamoli Director, Target Institute of Medical Education & Research, 402/A, Jaswanti Allied Business Center, Off Link Road, Malad West, Mumbai, India
  • Dr. Mahesh Kumar Harit Professor and Dean, D. Y. Patil Deemed to be University School of Ayurveda, Nerul, Sector1, Navi Mumbai, India
  • Dr.Narendra B. Mundhe Assistant Professor, Department of Kayachikitsa, KVTR Ayurvedic College Boradi, Tal. Shirpur, Dist.Dhule, India
  • Dr. Sudarshan Hande Associate Professor, D. Y. Patil Deemed to be University School of Ayurveda, Nerul, Sector1, Navi Mumbai, India
  • Ms. Kiran Khatau Director, 1415 West 22nd Street-Tower Floor,Oak Brook, Illinois 60523
  • Dr. Rajesh Giri Principal, KVTR Ayurvedic College Boradi,Tal.Shirpur,Dist., Dhule, India
  • Dr. Swapnali Mahadik Clinical Research Associate, Target Institute of Medical Education & Research, 402/A, Jaswanti Allied Business Center, Off Link Road, Malad West, Mumbai, India
  • Vinay Pawar School of Ayurveda, D. Y. Patil University, Sector 7
  • Dr. Ganesh Kolhe Assistant Professor, KVTR Ayurvedic College Boradi, Tal. Shirpur, Dist - Dhule, India

DOI:

https://doi.org/10.53555/ans.v7i4.1557

Keywords:

Ashwadaat®, Withania somnifera, Insomnia, Stress

Abstract

Introduction: Ashwadaat® is a proprietary extract based on standardized Ashwagandha (Withania somnifera) extract, which is a herb possessing anti-stress, anti-anxiety, anti- depressant, and sleep inducing properties.

Objective: The objective of the study was to evaluate efficacy and safety of Ashwadaat® in individuals with Stress and Insomnia.

Methods: In an Open label, multi centre, non-comparative, interventional, prospective clinical study carried out at two study sites, 30 individuals suffering from Stress and Insomnia were considered for the study after obtaining ethical clearance & informed consent.  Study participants were advised to take Ashwadaat® in a dose of 2 Capsules twice daily (500 mg Ashwadaat®) for a period of 30 days. Assessment of efficacy was done by stress by Perceived Stress Scale (PSS), severity of Insomnia on Insomnia Severity Index, assessment of quality of life (QOL) on GHQ28 scale and Serum Cortisol level (Morning). Safety related blood investigations were done for assessment of safety.

Results:

There was statistically significant reduction in stress and insomnia with the use of Ashwadaat®. A significant improvement in sleep quality along with improvement of quality of life (QOL) was seen at day 15 and day 30 as compared to the baseline scores. There was a reduction in morning Serum cortisol levels (within normal range) from baseline to 30 days. Excellent tolerability was reported over 30 days of consumption of Ashwadaat®. There were no adverse effects due to the consumption of Ashwadaat® and also the safety related laboratory parameters were within the normal range at baseline and further at the end of the study.

Conclusion: Ashwadaat® was found to be effective in reduction of stress and other associated symptoms, also effective in improving sleep quality, quality of life, without producing any adverse effects.

Downloads

Download data is not yet available.

References

1. Simandan D. On how much one can take: relocating exploitation and exclusion within the broader framework of allostatic load theory: Health &Place. 2010; 16(6): 1291–1293.
2. Yaribeygi H, Panahi Y, Sahraei H, Johnston PT, Sahebkar A: The impact of stress on body function: a review. XCLI Journal. 2017; 16: 1057.
3. Punnoose AR, Golub RM, Burke AE. JAMA patient page. Insomnia. JAMA. 2012 Jun 27; 307(24): 2653.
4. Roth T. "Insomnia: Definition, prevalence, etiology, and consequences". Journal of Clinical Sleep Medicine. 2007; 3 (5 Suppl): S7.
5. Basu M, Chatterjee S, De A, Sinha D, Ahamed A, Misra R. A Study on Prevalence of Chronic Insomnia and its Association with Medical Co-morbidities among Patients Attending General Out Patient Department (OPD) of a Tertiary Care Hospital of Kolkata, India. International Journal of Contemporary Medical Research. May 2017; 4 (5): 77.
6. Buysse D. Chronic Insomnia. The American journal of psychiatry. 2008; 165:678.
7. Wilson, JF. In the clinic. Insomnia. Annals of Internal Medicine. 2008: 148(1); ITC13-11-ITC13-1116.
8. Qaseem A, Kansagara D, Forciea MA, Cooke M, Denberg TD. Management of Chronic Insomnia Disorder in Adults: A Clinical Practice Guideline From the American College of Physicians". Annals of Internal Medicine. 165(2):125.
9. Khawam E, Laurencic, Malone D. Side effects of antidepressants: An overview. Cleveland Clinic journal of medicine. April 2006: 73. 351.
10. Han KS, Kim L, Shim I. Stress and sleep disorder. Experimental neurobiology, 2012: 21(4); 141–150.
11. Uddin Q, Samiulla L., Singh VK, Jamil SS. Phytochemical and pharmacological profile of Withania somnifera dunal: A review. Journal of Applied Pharmaceutical Science. 2012; 170.
12. Chandrasekhar K, Kapoor J, Anishetty A. A Prospective, Randomized Double-Blind, Placebo- Controlled Study of Safety and Efficacy of a High- Concentration Full-Spectrum Extract of Ashwagandha Root in Reducing Stress and Anxiety in Adults. Indian Journal of Psychological Medicine. Jul – Sep 2012: 34 (3); 255.
13. Langade D, Kanchi S, Salve J, Debnath K, Ambegaokar D. Efficacy and Safety of Ashwagandha (Withania somnifera) Root Extract in Insomnia and Anxiety: A Double-blind, Randomized, Placebo-controlled Study. Cureus. 2019 Sep 28; 11(9): e5797.
14. Damanhouri ZA, Ahmad A (2014) A Review on Therapeutic Potential of Piper nigrum L. (Black Pepper): The King of Spices. Med Aromat Plants 3: 161.
15. Mhaske DB, Sreedharan S, Mahadik KR (2018) Role of Piperine as an Effective Bioenhancer in Drug Absorption 9: 591.
16. State of New Hampshire Employee Assistance Program Available on https://das.nh.gov/wellness/docs/percieved%20stress%20scale.pdf accessed on 22nd March, 2021.
17. Morin CM; Belleville G; Bélanger L; Ivers H. The insomnia severity index: psychometric indicators to detect insomnia cases and evaluate treatment response. SLEEP 2011;34(5):601-608.
18. Sterling, M. General Health Questionnaire-28 (GHQ-28). Journal of physiotherapy. 57. 259. 10.1016/S1836-9553(11)70060-1.
19. Trauer JM, Qian MY, Doyle JS, Rajaratnam SM, Cunnington D. Cognitive Behavioral Therapy for Chronic Insomnia: A Systematic Review and Meta-analysis. Ann Intern Med. 2015 Aug 4;163(3):191.
20. Gajarmal A, Shende MB, Chothe DS. Antistress Activity of Ashwagandha (Withania Somnifera Dunal) - A Review. IAMJ. June 2014: 2 (3); 386.

Downloads

Published

2021-06-30

How to Cite

Tamoli, S., Harit, M. K. ., Mundhe, N., Hande, S., Khatau, K., Giri, R. ., Mahadik, S., Pawar, V., & Kolhe, G. (2021). Evaluation of Efficacy and Safety of Ashwadaat-TM Botanical Extract in Patients with Stress and Insomnia – An Open Label, Multi Center, Non-Comparative, Interventional, Prospective Clinical Study: Efficacy and Safety of Ashwadaat-TM in Patients with Stress and Insomnia. International Journal For Research In Applied And Natural Science, 7(4), 06–11. https://doi.org/10.53555/ans.v7i4.1557

Issue

Vol. 7 No. 4 (2021): International Journal For Research In Applied And Natural Science (ISSN: 2208-2085)

Section

Articles

License

Copyright (c) 2021 International Journal For Research In Applied And Natural Science (ISSN: 2208-2085)

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

In consideration of the journal, Green Publication taking action in reviewing and editing our manuscript, the authors undersigned hereby transfer, assign, or otherwise convey all copyright ownership to the Editorial Office of the Green Publication in the event that such work is published in the journal. Such conveyance covers any product that may derive from the published journal, whether print or electronic. Green Publication shall have the right to register copyright to the Article in its name as claimant, whether separately
or as part of the journal issue or other medium in which the Article is included.

By signing this Agreement, the author(s), and in the case of a Work Made For Hire, the employer, jointly and severally represent and warrant that the Article is original with the author(s) and does not infringe any copyright or violate any other right of any third parties, and that the Article has not been published elsewhere, and is not being considered for publication elsewhere in any form, except as provided herein. Each author’s signature should appear below. The signing author(s) (and, in